[Chung Chan-seung] The collapse of trust: South Korea's true health care crisis
[KH Explains] Why doctors refuse to bend despite lack of public support
[KH Explains] What does Apple's dead car project mean for Samsung, Hyundai?
Actor Lee Jae-wook vows legal action against malicious rumors
Yoon, Zuckerberg discuss AI, digital ecosystem in Seoul
Interior minister renews calls for trainee doctors to return to work
Police raid striking doctors' homes, offices, after deadline passes on return-to-work order
Bitcoin soars to record high in Korea
S. Korea, US voice 'deep concern' over NK's definition of S. Korea as 'hostile' country
[Graphic News] S. Korean children’s screen time 3 times WHO recommendation
Korea Ginseng teams up with International Vaccine Institute to develop immune boosterBy Yim Hyun-su
Published : Dec. 4, 2020 - 15:06
The two will work together to develop an adjuvant using Korea Ginseng’s popular red ginseng brand CheongKwanJang, the company said Friday.
Korea Ginseng will provide 12 types of ginsenosides while the institute, a nonprofit organization that is working with vaccine companies to develop COVID-19 vaccines, will conduct research into their effectiveness as an immune booster.
The company added that findings from the research could help vaccine development.
Dr. Song Man-ki, the institute’s acting deputy director general of science, said the new research is part of many efforts to develop an adjuvant for various vaccines including ones against COVID-19.
Park Chae-kyu, head of Korea Ginseng’s research and development unit, said he expects the newly signed memorandum to increase the value of red ginseng.
By Yim Hyun-su (firstname.lastname@example.org)
Yoon touts improved Japan ties on Independence Movement Day
Bill to probe first lady fails to pass
Address by President Yoon Suk Yeol on the 105th March 1st Independence Movement Day